Home
Scholarly Works
CSACI position statement: prescribing sublingual...
Journal article

CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens

Authors

Quirt J; Gagnon R; Ellis AK; Kim HL

Journal

Allergy, Asthma & Clinical Immunology, Vol. 14, No. 1,

Publisher

Springer Nature

Publication Date

January 9, 2018

DOI

10.1186/s13223-017-0225-6

ISSN

1710-1484

Contact the Experts team